FIELD: medicine, pharmaceutics.
SUBSTANCE: the suggested composition includes therapeutically efficient quantity of para-aminosalicylic acid (PASA) as an active substance and target additives as sorbitol, polyvinyl pyrrolidone, salt of stearic acid, talc and citric acid. Pharmaceutical composition is designed as tablets covered with a membrane. The latter contains either "Acryl-iz" of Calarcon firm or composition consisting of copolymer of methacrylic acid with ethylacrylate, titanium dioxide, talc, propylene glycol and iron oxide. The suggested PASA-based antitubercular preparation meets all normative requirements of the State Pharmacopoeia, XI publication and has expiry terms of 2 yr.
EFFECT: higher efficiency of application.
6 cl, 3 ex, 1 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 | 
 | RU2436580C1 | 
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 | 
 | RU2424808C2 | 
| PHARMACEUTICAL COMPOSITION WITH ANTI-TUBERSULOSIS ACTION | 2009 | 
 | RU2420288C1 | 
| COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 | 
 | RU2417087C2 | 
| COMBINED ANTITUBERCULOUS COMPOSITION | 2009 | 
 | RU2413517C1 | 
| COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 | 
 | RU2422145C2 | 
| COMBINED ANTITUBERCULOUS COMPOSITION | 2010 | 
 | RU2468802C2 | 
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES MELLITUS (VARIANTS) | 2003 |  | RU2241449C1 | 
| MEDICATION FOR TUBERCULOSIS TREATMENT | 2009 | 
 | RU2405554C1 | 
| ANTITUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING THIOACETAZONE | 2015 | 
 | RU2627611C2 | 
Authors
Dates
2005-03-27—Published
2004-02-09—Filed